Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Am J Gastroenterol. 2013 Apr 9;108(6):915–922. doi: 10.1038/ajg.2013.72

Table 1.

Distributions of characteristics of cases and controls

Variable BE cases
(n = 236)
Primary-care
controls (n = 447)
P valuea
n (%) n (%)
Demographics
  Mean age, year (s.d.) 61.8 (7.1) 62.1 (6.7) 0.58
  Male 229 (97.0) 431 (96.4) 0.67
  White 205 (86.9) 247 (55.3) <0.001
Education
  School only 105 (44.5) 203 (45.4) 0.83
  Technical college/diploma 82 (34.7) 156 (34.9)
  University 47 (19.9) 81 (18.1)
  Missing 2 (0.9) 7 (1.6)
BMI
  Mean (s.d.) 30.3 (5.5) 30.8 (6.3) 0.99
  <25.0 37 (15.7) 71 (15.9)
  25.0–29.9 82 (34.7) 155 (34.7)
  ≥30 117 (49.6) 221 (49.4)
Cumulative smoking exposure
  Never smoker 54 (22.9) 111 (24.8) 0.26
  0–29.9 pack-years 89 (37.7) 188 (42.1)
  ≥30 pack-years 93 (39.4) 148 (33.1)
Alcohol-drinking status
  Nondrinker 18 (7.6) 29 (6.5) 0.70
  Ex-drinker 88 (37.3) 163 (36.5)
  Current drinker 130 (55.1) 253 (56.6)
  Missing 0 (0.0) 2 (0.4)
Helicobacter pylori status
  Negative 189 (80.1) 283 (63.3) <0.001
  Positive 41 (17.4) 151 (33.8)
  Missing 6 (2.5) 13 (2.9)
Medications
  Ever used PPIs 171 (72.5) 99 (22.2) <0.001
  Ever used H2RA 22 (9.3) 26 (5.8) 0.09
  Aspirin or NSAIDs in the last year 145 (61.4) 280 (62.6) 0.76

BE, Barrett’s esophagus; BMI, body mass index; H2RA, H2-receptor antagonist; NSAID, nonsteroidal anti-inflammatory drug; PPI, proton pump inhibitor; s.d., standard deviation.

a

P values were for the comparison between cases and controls and were obtained using Student’s t-test for continuous variables and χ2-tests for categorical variables.